Immunotherapy

Category

Top Oncology Investigator Dr. Anthony Tolcher (Next Oncology) Selected by Heat Biologics to Lead Novel Phase I Oncology Study

Anthony Tolcher, MD, FRCPC, a medical oncologist and co-founder of research organization NEXT Oncology has been appointed the lead investigator for a Phase I clinical trial investigating Heat Biologics’ investigational therapy called PTX-35, a novel potential...

Stakes Get Bigger as Patient Health and Success of Humanigen Platform Depend on Evidence from COVID-19 Clinical Trials

San Francisco Bay Area biotech venture Humanigen, Inc. (HGEN), formerly known as KaloBios Pharmaceuticals, is a clinical stage company focused on preventing and treating cytokine storm with lenzilumab, their proprietary Humaneered® anti-human granulocyte...

Detroit-Area Couple Contribute $40m to Leading Cancer Research Center

A local Detroit area couple, active in philanthropy locally and nationally, announced a $40 million gift to the Karmanos Cancer Institute in Detroit, Michigan. Danialle and Pete Karmanos seek to help cancer patients receiving immunotherapy as well as other measures to...

Arkansas Children’s Research Institute 18-year Research Journey Pays off with Approval of First Peanut Allergy Drug

The Arkansas Children’s Research Institute, located on the campus of Arkansas Children’s Hospital, spent 18 years working on the drug Palforzia, recently approved by the U.S. Food and Drug Administration for treating patients with peanut allergies. Dr. Stacie Jones,...

Pin It on Pinterest